"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Descriptor ID |
D008545
|
MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 1 | 5 |
1996 | 12 | 2 | 14 |
1997 | 8 | 0 | 8 |
1998 | 9 | 0 | 9 |
1999 | 9 | 1 | 10 |
2000 | 14 | 1 | 15 |
2001 | 13 | 3 | 16 |
2002 | 16 | 3 | 19 |
2003 | 14 | 2 | 16 |
2004 | 13 | 2 | 15 |
2005 | 9 | 1 | 10 |
2006 | 22 | 2 | 24 |
2007 | 20 | 1 | 21 |
2008 | 25 | 4 | 29 |
2009 | 24 | 3 | 27 |
2010 | 19 | 5 | 24 |
2011 | 36 | 4 | 40 |
2012 | 27 | 2 | 29 |
2013 | 27 | 6 | 33 |
2014 | 31 | 4 | 35 |
2015 | 31 | 0 | 31 |
2016 | 19 | 0 | 19 |
2017 | 45 | 0 | 45 |
2018 | 25 | 1 | 26 |
2019 | 36 | 0 | 36 |
2020 | 36 | 5 | 41 |
2021 | 27 | 1 | 28 |
2022 | 31 | 0 | 31 |
2023 | 29 | 0 | 29 |
2024 | 23 | 3 | 26 |
2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice. Arch Dermatol Res. 2025 Feb 19; 317(1):438.
-
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma. J Immunother Cancer. 2025 Feb 12; 13(2).
-
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial. Nat Med. 2025 Jan; 31(1):144-151.
-
Causal models and prediction in cell line perturbation experiments. BMC Bioinformatics. 2025 Jan 07; 26(1):4.
-
Cognitive impairment in patients with melanoma before adjuvant immune checkpoint inhibitor therapy and associations with brain gray matter, catechol-O-methyltransferase genotype, and psychological factors. Cancer. 2025 Jan 15; 131(2):e35683.
-
Diet and Immune Effects Trial (DIET)- a randomized, double-blinded dietary intervention study in patients with melanoma receiving immunotherapy. BMC Cancer. 2024 Dec 04; 24(1):1493.
-
Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
-
Engineering immunity: bacterial delivery of cancer neoantigen vaccines. Trends Immunol. 2024 Dec; 45(12):931-933.
-
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. J Immunother Cancer. 2024 Nov 12; 12(11).
-
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review. Curr Oncol Rep. 2024 Dec; 26(12):1612-1638.